Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Surgical Technology _ Cardiovascular, Cardiac & Cardiology Companies
Sensydia

Organization & Developments: Sensydia

Parents

2022: Sensydia Receives FDA Breakthrough Device Designation for CPSTM Non-Invasive Cardiac Monitoring Device
2023: Sensydia receives funding for AI-driven cardiac assessment_ NIH's National Heart, Lung and Blood Institute has given Sensydia a Fast-Track Small Business grant worth $3 million
With its Cardiac Performance System (CPSTM), Sensydia is developing a new cardiac monitoring technology that enables more effective management of patients anywhere in the continuum of the heart failure spectrum without the need for in-hospital procedures or multiple diagnostic tests.